Project Grant R01MH144654
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Regents of the University of California, San Francisco a Project Grant of $458,177 under the Mental Health Research Grants program (CFDA 93.242) for the period June 9, 2025 through June 8, 2027. The research project, titled "Leveraging Population Level Data to Inform Prevention and Treatment of Adolescent Depression Following Social Adversities," addresses the significant gap between current...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a Project Grant (R21) of $436,934 to the University of California, Los Angeles, effective June 1, 2026 through May 31, 2028, under the Mental Health Research Grants program (CFDA 93.242). This research project will deliver longitudinal analysis and evidence-based findings on suicidal thoughts and behaviors (STBs) trajectories in Mexican-origin youth, addressing a significant gap in mental health research for an...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Research Foundation For Mental Hygiene, Inc., a $868,015 Project Grant on June 12, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and implement the SAFER (Suicide Assessment and Follow-up After Emergency Department Release) initiative. This research project, which extends through February 28, 2031, addresses the critical public health concern of suicide among children aged 8-12...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a Project Grant of $442,750 to the University of California, Davis, under the Mental Health Research Grants program (CFDA 93.242) for the period April 1, 2026 through March 31, 2028. This award funds the development of novel statistical methodologies designed to predict individualized intervention effects in datasets characterized by clustering and longitudinal measurements. The primary deliverables include...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $863,276 to the University of California, San Francisco under the Mental Health Research Grants program (CFDA 93.242) on February 3, 2026, for a project grant titled "Resilience in Action: Assessing the Behavioral Target Mechanisms of the RIA Curriculum in Young Adults with Autism." The primary deliverable is a rigorous evaluation of the Resilience in Action (RIA) curriculum, a previously pilot-tested...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a K99/R00 Pathway to Independence grant totaling $117,263 to the University of California, Los Angeles on May 6, 2026, under the Mental Health Research Grants program (CFDA 93.242). This award supports a translational multimodal research initiative focused on predicting risk and resilience in psychosis and bipolar spectrum disorders through the development of individualized novel phenotyping methods and machine...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Illinois a Project Grant totaling $100,228 under the Mental Health Research Grants program (CFDA 93.242) to implement suicide prevention strategies in outpatient pediatric behavioral health settings. The project, which commenced on September 30, 2026, and concludes on May 31, 2028, will deliver qualitative research findings and contextually tailored implementation strategies designed to...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Rochester a $174,381 Project Grant effective September 1, 2025, through August 31, 2029, under the Mental Health Research Grants program (CFDA 93.242). This award funds the development and testing of Cognitive Behavioral Therapy for Treatment-Seeking (CBT-TS) specifically adapted for deaf individuals, a historically understudied and underserved population experiencing elevated rates of suicidal...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a $854,029 Project Grant on September 1, 2025, under the Mental Health Research Grants program (CFDA 93.242) to develop and evaluate a multimodality adaptive intervention for reducing suicide risk in the critical three-month period following inpatient psychiatric hospitalization. The grant supports a five-year research initiative (through August 31, 2030) employing a hybrid...
- Federal Grant Award Summary Bend Health, Inc. received a $291,491 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective August 1, 2025, through July 31, 2028. The award funds the development and feasibility testing of an enhanced digital mental health intervention designed to address self-injurious thoughts or behaviors (SITBs) among adolescents. Specifically, Bend Health will expand its existing Remote Rapid...
The National Institute of Mental Health (NIMH) awarded UC San Diego a $396,907 Project Grant on June 5, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and evaluate Recovery Integrated Safety and Engagement (RISE), a novel peer-supported suicide prevention intervention for individuals at clinical high risk for psychosis (CHR). The three-year project, concluding March 31, 2029, will deliver a refined, evidence-based group intervention that combines therapist and peer co-facilitation with four recovery-oriented modules—Reasons for Living, Hope, Recovery Goals, and Social Connection—integrated with compensatory cognitive strategies and a caregiver means restriction session. The study will produce preliminary effectiveness data, implementation guidance, and protocol refinements suitable for routine clinical care settings. The grant follows a hybrid effectiveness-implementation framework across two sites, generating deliverables through three primary aims: (1) protocol refinement through qualitative interviews and community input with an open trial to assess fidelity; (2) a pilot randomized controlled trial comparing RISE to treatment as usual to evaluate preliminary effectiveness on suicide ideation and intervention targets; and (3) qualitative implementation data from participant and administrator/clinician interviews. These products—including the refined intervention manual, effectiveness outcomes, and implementation science findings—will address a critical gap in suicide prevention approaches for the CHR population, where suicide risk remains elevated but standardized prevention protocols are lacking.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $396.9k | 6/8/26 |